<p>Vincent Vultaggio, PAO and PFO of Zentalis Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zentalis Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002018766-26-000006), on February 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

ARKG

Reuters

Invesco Biotechnology & Genome ETF

Ark Genomic Revolution ETF

VG Health

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

iShares US Pharma

iShares Biotechnology ETF

Health Care Select Sector SPDR

SPDR S&P Biotech

ZeZentalis Pharma

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

Zentalis Pharmaceuticals PAO and PFO Vincent Vultaggio Reports Disposal of Common Shares